Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Spliceosome mutations in AML: Prevalence, clinical features, and treatment outcomes in a contemporary cohort

View Full Paper
Ask AI
Bookmark
Share

Authors

EZEmily C. ZaborMAMoath AlbliwiABAmeed Bawwab

Discussion

Loading...

Member takes

Overview

Retrospective cohort analysis shows spliceosome mutations in AML associate with baseline characteristics but not clinical outcomes.

Key Points

  • To examine the prevalence and clinical significance of spliceosome mutations in acute myeloid leukemia (AML).
  • Conducted a retrospective cohort study of AML patients
  • Collected data on mutations, age, gender, ethnicity, and cytogenetics
  • Utilized next-generation sequencing for mutational profiles
  • Analyzed treatment outcomes using logistic and Cox proportional hazards models
  • Prevalence of spliceosome mutations varied with SRSF2 at 17% and U2AF1 at 7.2%
  • No significant differences in overall survival and event-free survival between mutated and wild type patients
  • Patients with spliceosome mutations had differing baseline characteristics but similar treatment responses

Cite This Study

Zabor et al. (2025) studied this question.

synapsesocial.com/papers/69362f574fa91c937236da5ahttps://doi.org/10.1182/blood-2025-3396
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical outcomes in spliceosome-mutant myelodysplastic neoplasms and Acute Myeloid Leukemia2025
  2. 2Poor Prognosis of SRSF2 Gene Mutations in Patients Treated with VEN-AZA for Newly Diagnosed Acute Myeloid Leukemia2024 · 6 citations
  3. 3Epigenetic dysregulation of the polycomb axis in Acute Myeloid Leukemia: Clinical and prognostic correlates2025
  4. 4Splicing factor mutations clearance and outcomes in clonal myeloid neoplasms: a referral center experience2026
  5. 5Additional myelodysplasia-related genes mutations affected the clinical presentations and prognosis of patients with SRSF2/TET2 co-mutations2025